IE 11 is not supported. For an optimal experience visit our site on another browser.

Artificial Life Launches GluCoMo(TM)

LOS ANGELES and HONG KONG, Sept. 10, 2010 (GLOBE NEWSWIRE) -- Artificial Life, Inc., (OTCBB:ALIF) (http://www.artificial-life.com), a leading provider of award-winning mobile 3G technology and applications, announced today the launch of GluCoMo (short for: "Glucose Monitor") on Apple's App Store. GluCoMo is the first in a series of planned mobile healthcare products. The application is offered free of charge.
/ Source: GlobeNewswire

LOS ANGELES and HONG KONG, Sept. 10, 2010 (GLOBE NEWSWIRE) -- Artificial Life, Inc., (OTCBB:ALIF) (), a leading provider of award-winning mobile 3G technology and applications, announced today the launch of GluCoMo™ (short for: "Glucose Monitor") on Apple's App Store. GluCoMo is the first in a series of planned mobile healthcare products. The application is offered free of charge.

GluCoMo is an electronic diary and reminder system designed for the specific needs of diabetics. GluCoMo keeps track of many diabetes-related activities in one centralized mobile hub. The comprehensive readings recorded within the app include: blood sugar level, insulin intake, weight, pulse, physical activity, dietary intake, blood pressure, and medication intake. Users of the app may adjust their activities by reviewing their entry history through easy-to-use informative graph visualizations. Automatic reminders may be added into the app to alert users of different health related activities. GluCoMo leverages Artificial Life's enterprise mobile platform solution, Opus-M™. 

Features of GluCoMo include:

  • Simple and easy data input
  • Interactive graphs to track and visualize measurements
  • Secure data back-up and recovery service
  • Automatic reminders
  • Informative handbook for acquiring facts about diabetes
  • Online interaction and sharing with other users through built-in forums
  • Integration with social communities such as Twitter

 "Artificial Life has launched its first telemedicine product: GluCoMo. This marks the expansion of our business into mobile lifestyle and healthcare apps. We will continue to develop more business applications in niche markets across different platforms," said Eberhard Schoneburg, CEO of Artificial Life, Inc.

To download the GluCoMo application free of charge, please go to: 

To learn more about GluCoMo, please visit:

About Artificial Life, Inc.

Artificial Life, Inc. has been a pioneer in artificial intelligence and mobile technology since its inception in Boston in 1994. We are a public US corporation (OTCBB:ALIF) with listing on the Frankfurt Stock Exchange (Frankfurt:AIF) (XETRA:AIF) and headquarters in Hong Kong. Our production center is in Hong Kong and we have additional offices in Berlin, Germany (EMEA headquarters) and Tokyo, Japan. As a leading provider of broadband mobile content and technology solutions in the world, we develop and sell a wide range of mobile applications for 3G, 3.5G and 4G network-enabled mobile (smart) phones. Currently our main business areas are: high quality 3D interactive (massive multiplayer) mobile games, mobile participation television, mobile business applications and our mobile commerce technology platform OPUS-M. We are supporting all major mobile phone operating systems and platforms. Recognized internationally for outstanding content quality and technology, we have received many international awards and have been ranked one of the fastest growing companies in Asia Pacific by Deloitte.

The Artificial Life logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=1669

For more information about Artificial Life, Inc., please visit our website  www.artificial-life.com or our product websites: www.botme.com, www.mopa-tv.com, www.opus-m.com, www.glucomo.com, www.greencortex.com .

Facebook:

Twitter:

MySpace:

Youtube:

Forward-Looking Statements:

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, without limitation, statements regarding our future results of operations, financial condition and business prospects. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue" or the negative of these terms or other comparable terminology. Although such statements are based on our own information and information from other sources we believe to be reliable, you should not place undue reliance on them. These statements involve risks and uncertainties, and actual market trends or our actual results of operations, financial condition or business prospects may differ materially from those expressed or implied in these forward-looking statements for a variety of reasons. Potential risks and uncertainties include, but are not limited to, our ability to obtain additional funding to operate and grow our business; the unproven potential of our mobile gaming business model; changing consumer preferences and uncertainty of market acceptance of our products; timely adoption and availability of 3G mobile technology; market acceptance for use of mobile handheld devices to play the interactive games; unpredictable mobile game development schedules; our reliance on a relatively small number of brands; our ability to license brands from others; our dependence upon resellers and telecommunication carriers and operators to distribute our products; our ability to successfully develop, introduce, and sell new or enhanced products in a timely manner; and the timing of new product announcements or introductions by us or by our competitors. For additional discussion of these risks and uncertainties and other factors, please see the documents we file from time to time with the Securities and Exchange Commission, including our Annual Report on Form 10-KSB filed on March 16, 2010. We assume no obligation to update any forward-looking statements, which apply only as of the date of this press release.

CONTACT: Artificial Life, Inc. IR and PR Contact: Adeline Law (+852) 3102 2800 ir@artificial-life.com